Nkarta (NKTX) Stock Forecast & Price Target

Compare

639 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

NKTX Analyst Ratings

Strong Buy

5 Buy

1 Hold

0 Sell

Based on 6 analysts giving stock ratings to

Nkarta

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

NKTX Stock 12 Month Forecast

Average Price Target

$12.50

▲(618.39%Upside)

Based on 6 Wall Street analysts offering 12 month price targets for Nkarta in the last 3 months. The average price target is $12.50 with a high forecast of $18.00 and a low forecast of $8.00. The average price target represents a 618.39% change from the last price of $1.74.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"$0","19":"$19","4.75":"$4.75","9.5":"$9.5","14.25":"$14.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":18,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$18.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":12.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$12.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":8,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$8.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,4.75,9.5,14.25,19],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2024","6":"Aug<br/>2024","9":"Feb<br/>2025","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.05,3.276923076923077,4.503846153846153,5.73076923076923,6.957692307692307,8.184615384615384,9.41153846153846,10.638461538461538,11.865384615384613,13.092307692307692,14.319230769230767,15.546153846153846,16.77307692307692,{"y":18,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.05,2.8538461538461535,3.657692307692307,4.461538461538462,5.265384615384615,6.069230769230769,6.873076923076923,7.676923076923076,8.48076923076923,9.284615384615384,10.088461538461537,10.892307692307693,11.696153846153845,{"y":12.5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.05,2.5076923076923077,2.9653846153846155,3.423076923076923,3.8807692307692307,4.338461538461539,4.796153846153846,5.253846153846154,5.711538461538462,6.1692307692307695,6.626923076923077,7.084615384615385,7.542307692307692,{"y":8,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":10.61,"date":1706745600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.84,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.82,"date":1711929600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.49,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.79,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.85,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.41,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.21,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.19,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.34,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.75,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.84,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.05,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$18.00

Average Price Target$12.50

Lowest Price Target$8.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Sami CorwinWilliam Blair

William Blair

―

Hold

―

Downgraded

05/17/25

Nkarta (NKTX) was downgraded to a Hold Rating at William Blair

Emily BodnarH.C. Wainwright

H.C. Wainwright

$18

Buy

934.48%

Upside

Reiterated

05/15/25

Analysts Offer Insights on Healthcare Companies: Verve Therapeutics (NASDAQ: VERV), Nkarta (NASDAQ: NKTX) and Kamada (NASDAQ: KMDA)

Gil BlumNeedham

Needham

$11→$10

Buy

474.71%

Upside

Reiterated

05/15/25

Analysts Offer Insights on Healthcare Companies: Organon (NYSE: OGN), Diamedica Therapeutics (NASDAQ: DMAC) and Nkarta (NASDAQ: NKTX)

Daina GrayboschLeerink Partners

Leerink Partners

Buy

359.77%

Upside

Reiterated

05/15/25

Nkarta's Strategic Enhancements in NKX019 Program and Trial Expansion Drive Positive Buy Rating

Yaron WerberTD Cowen

TD Cowen

―

Buy

―

Reiterated

05/14/25

TD Cowen Remains a Buy on Nkarta (NKTX)

Stephen WilleyStifel Nicolaus

Stifel Nicolaus

$15→$14

Buy

704.60%

Upside

Reiterated

03/27/25

Nkarta price target lowered to $14 from $15 at StifelNkarta price target lowered to $14 from $15 at Stifel

Salim SyedMizuho Securities

Mizuho Securities

$20→$16

Buy

819.54%

Upside

Reiterated

11/21/24

Nkarta price target lowered to $16 from $20 at MizuhoNkarta price target lowered to $16 from $20 at Mizuho

Anthony ButlerRodman & Renshaw

Rodman & Renshaw

$14

Buy

704.60%

Upside

Initiated

10/09/24

Nkarta initiated with a Buy at Rodman & RenshawNkarta initiated with a Buy at Rodman & Renshaw

Laura PrendergastRaymond James

Raymond James

$16

Buy

819.54%

Upside

Upgraded

08/14/24

Raymond James upgrades Nkarta Inc. (NKTX) to Strong BuyRaymond James analyst Laura Prendergast upgraded Nkarta Inc. (NASDAQ: NKTX) from Outperform to Strong Buy with a price target of $16.00.

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Sami CorwinWilliam Blair

William Blair

―

Hold

―

Downgraded

05/17/25

Nkarta (NKTX) was downgraded to a Hold Rating at William Blair

Emily BodnarH.C. Wainwright

H.C. Wainwright

$18

Buy

934.48%

Upside

Reiterated

05/15/25

Analysts Offer Insights on Healthcare Companies: Verve Therapeutics (NASDAQ: VERV), Nkarta (NASDAQ: NKTX) and Kamada (NASDAQ: KMDA)

Gil BlumNeedham

Needham

$11→$10

Buy

474.71%

Upside

Reiterated

05/15/25

Analysts Offer Insights on Healthcare Companies: Organon (NYSE: OGN), Diamedica Therapeutics (NASDAQ: DMAC) and Nkarta (NASDAQ: NKTX)

Daina GrayboschLeerink Partners

Leerink Partners

Buy

359.77%

Upside

Reiterated

05/15/25

Nkarta's Strategic Enhancements in NKX019 Program and Trial Expansion Drive Positive Buy Rating

Yaron WerberTD Cowen

TD Cowen

―

Buy

―

Reiterated

05/14/25

TD Cowen Remains a Buy on Nkarta (NKTX)

Stephen WilleyStifel Nicolaus

Stifel Nicolaus

$15→$14

Buy

704.60%

Upside

Reiterated

03/27/25

Nkarta price target lowered to $14 from $15 at StifelNkarta price target lowered to $14 from $15 at Stifel

Salim SyedMizuho Securities

Mizuho Securities

$20→$16

Buy

819.54%

Upside

Reiterated

11/21/24

Nkarta price target lowered to $16 from $20 at MizuhoNkarta price target lowered to $16 from $20 at Mizuho

Anthony ButlerRodman & Renshaw

Rodman & Renshaw

$14

Buy

704.60%

Upside

Initiated

10/09/24

Nkarta initiated with a Buy at Rodman & RenshawNkarta initiated with a Buy at Rodman & Renshaw

Laura PrendergastRaymond James

Raymond James

$16

Buy

819.54%

Upside

Upgraded

08/14/24

Raymond James upgrades Nkarta Inc. (NKTX) to Strong BuyRaymond James analyst Laura Prendergast upgraded Nkarta Inc. (NASDAQ: NKTX) from Outperform to Strong Buy with a price target of $16.00.

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Nkarta

1 Month

xxx

Success Rate

10/17 ratings generated profit

Average Return

+10.54%

reiterated a xxx

rating 14 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 58.82% of your transactions generating a profit, with an average return of +10.54% per trade.

3 Months

xxx

Success Rate

11/28 ratings generated profit

Average Return

+21.15%

reiterated a xxx

rating 6 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 39.29% of your transactions generating a profit, with an average return of +21.15% per trade.

1 Year

Daina GrayboschLeerink Partners

Success Rate

6/17 ratings generated profit

Average Return

-11.29%

reiterated a buy rating 14 days ago

Copying Daina Graybosch's trades and holding each position for 1 Year would result in 35.29% of your transactions generating a profit, with an average return of -11.29% per trade.

2 Years

xxx

Success Rate

2/17 ratings generated profit

Average Return

-49.44%

reiterated a xxx

rating 14 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 11.76% of your transactions generating a profit, with an average return of -49.44% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

NKTX Analyst Recommendation Trends

Rating

Nov 24

Feb 25

Mar 25

Apr 25

May 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, NKTX has received 11 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. NKTX average Analyst price target in the past 3 months is 12.50.

Each month's total comprises the sum of three months' worth of ratings.

NKTX Financial Forecast

NKTX Earnings Forecast

Next quarter’s earnings estimate for NKTX is -$0.35 with a range of -$0.50 to -$0.25. The previous quarter’s EPS was -$0.43. NKTX beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.23% of the time in the same period. In the last calendar year NKTX has Preformed in-line its overall industry.

No data currently available

NKTX Sales Forecast

Next quarter’s sales forecast for NKTX is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. NKTX beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.54% of the time in the same period. In the last calendar year NKTX has Preformed in-line its overall industry.

NKTX Stock Forecast FAQ

What is NKTX’s average 12-month price target, according to analysts?

Based on analyst ratings, Nkarta, Inc.’s 12-month average price target is 12.50.

What is NKTX’s upside potential, based on the analysts’ average price target?

Nkarta, Inc. has 618.39% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is NKTX a Buy, Sell or Hold?

Nkarta, Inc. has a consensus rating of Strong Buy which is based on 5 buy ratings, 1 hold ratings and 0 sell ratings.

What is Nkarta, Inc.’s price target?

The average price target for Nkarta, Inc. is 12.50. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $18.00 ,the lowest forecast is $8.00. The average price target represents 618.39% Increase from the current price of $1.74.

What do analysts say about Nkarta, Inc.?

Nkarta, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Streets Analysts.

How can I buy shares of NKTX?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Nkarta (NKTX) Stock Forecast & Price Target

NKTX Analyst Ratings

NKTX Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Nkarta

NKTX Analyst Recommendation Trends

NKTX Financial Forecast

NKTX Earnings Forecast

NKTX Sales Forecast

NKTX Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts